During the past decade, Innovative Medical Technologies conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Innovative Medical Technologies" #1 sponsor was "Pfizer" with 2 trials, followed by "3M" with 1 trials sponsored, "DIApedia, LLC" with 1 trials sponsored, "Healthpoint" with 1 trials sponsored and "Tissue Repair Company" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Innovative Medical Technologies" #1 collaborator was "Cardium Therapeutics" with 1 trials as a collaborator and "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Innovative Medical Technologies" are "Diabetes Complications" (2 trials), "Diabetic Foot Ulcers" (2 trials), "Foot Ulcer, Diabetic" (2 trials), "Diabetes" (1 trials) and "Diabetic Foot" (1 trials). Many other conditions were trialed in "Innovative Medical Technologies" in a lesser frequency.

Most popular intervention types in "Innovative Medical Technologies" are "Device" (3 trials), "Drug" (2 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "MRE0094" (2 trials), "Current standard of care insole" (1 trials), "GAM501" (1 trials), "HP828-101" (1 trials) and "Hydrogel/Hydrocolloid" (1 trials). Other intervention names were less common.

The vast majority of trials in "Innovative Medical Technologies" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Innovative Medical Technologies". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Innovative Medical Technologies, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Innovative Medical Technologies, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".